Literature DB >> 1350605

Flavimonas oryzihabitans (CDC group Ve-2) bacteraemia associated with Hickman catheters.

A Conlu1, J Rothman, H Staszewski, P E Schoch, P Domenico, S M Quadri, B A Cunha.   

Abstract

Flavimonas oryzihabitans is a potential pathogen that may infect patients who have major medical illnesses, especially those who are undergoing surgery or have indwelling venous catheters in situ. Flavimonas oryzihabitans has been isolated from a wide range of body sites, and the portals of entry are major wounds or implanted foreign materials. We report two cases of F. oryzihabitans bacteraemia associated with the use of Hickman catheters for administration of the patients' chemotherapeutic agents. However, a common source for these infections could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350605     DOI: 10.1016/0195-6701(92)90007-9

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  4 in total

1.  Infection of hickman catheter by Pseudomonas (formerly flavimonas) oryzihabitans traced to a synthetic bath sponge.

Authors:  M Marín; D García de Viedma; P Martín-Rabadán; M Rodríguez-Créixems; E Bouza
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 2.  Infections due to Flavimonas oryzihabitans: case report and literature review.

Authors:  J Esteban; M L Valero-Moratalla; R Alcazar; F Soriano
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

3.  Epidemiological typing of Flavimonas oryzihabitans by PCR and pulsed-field gel electrophoresis.

Authors:  P Y Liu; Z Y Shi; Y J Lau; B S Hu; J M Shyr; W S Tsai; Y H Lin; C Y Tseng
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

4.  In vitro activities of antimicrobial agents against clinical isolates of Flavimonas oryzihabitans obtained from patients with cancer.

Authors:  K V Rolston; D H Ho; B LeBlanc; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.